Publications by authors named "Mario Otto"

Claim this Profile
A
A Unique Approach to Interdisciplinary Programmatic Palliative Care Development: Extending Into the Realm of Pediatric Palliative Oncology.
Allison Uber, Roberta H Adams, Shannon Marcus, Mario Otto, Tressia Shaw

Pediatr Blood Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive up-to-date analysis on TCRαβ/CD19-depleted hematopoietic stem cell transplantation in pediatric hematological malignancies.
Hussien Ahmed H Abdelgawad, Heba Aboeldahab, Mohamed Mohamed Belal, Mohamed Nabih Bashir, Holly K Miller, Mario Otto

Transpl Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nothing short of a revolution: Novel extended half-life factor VIII replacement products and non-replacement agents reshape the treatment landscape in hemophilia A.
Hussien Ahmed H Abdelgawad, Rachel Foster, Mario Otto

Blood Rev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy.
Prashant Sharma, Mario Otto

Bioact Mater· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Management of Prolonged, Recalcitrant Priapism in a Pediatric Patient.
Rachael Sherrer, Mario Otto, Sushant Srinivasan, Krista Grinde, Walid A Farhat

Pediatrics· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted treatment of multiple myeloma with a radioiodinated small molecule radiopharmaceutical.
Ankita Shahi, Gerald E Weiss, Saswati Bhattacharya, Dana C Baiu, Roberta Marino, Mario Otto

Leuk Lymphoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors.
Lance T Hall, Benjamin Titz, Nishanta Baidya, Anja G van der Kolk, H Ian Robins, Mario Otto

Mol Imaging Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Pharmacokinetics and Dosimetry Studies of I/I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models.
Ian R Marsh, Joseph Grudzinski, Dana C Baiu, Abigail Besemer, Reinier Hernandez, Mario Otto

J Nucl Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data.
Kieran Sahasrabudhe, Mario Otto, Peiman Hematti, Vaishalee Kenkre

Leuk Lymphoma· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog.
Mohamed Y Elsaid, Ankita Shahi, Albert R Wang, Dana C Baiu, Chunrong Li, Mario Otto

Mol Cancer Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents.
Bryan Bednarz, Joseph Grudzinski, Ian Marsh, Abby Besemer, Dana Baiu, Mario Otto

Health Phys· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog.
Dana C Baiu, Ian R Marsh, Alexander E Boruch, Ankita Shahi, Saswati Bhattacharya, Mario Otto

J Nucl Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma.
Roberta Marino, Dana C Baiu, Saswati Bhattacharya, Benjamin Titz, Ellen Hebron, Mario Otto

Am J Cancer Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing both CT imaging and natural killer cell-mediated cancer cell killing by a GD2-targeting nanoconstruct.
Peifu Jiao, Mario Otto, Qiaohong Geng, Chencan Li, Faming Li

J Mater Chem B· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide nanoparticles.
Dana C Baiu, Nathan S Artz, Meghan R McElreath, Bryan D Menapace, Diego Hernando, Mario Otto

Nanomedicine (Lond)· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in pediatric malignancies: current status and future perspectives.
Christian M Capitini, Mario Otto, Kenneth B DeSantes, Paul M Sondel

Future Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK cell-based immunotherapies in Pediatric Oncology.
Kimberly A McDowell, Jacquelyn A Hank, Kenneth B DeSantes, Christian M Capitini, Mario Otto

J Pediatr Hematol Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles.
Yaolin Xu, Dana C Baiu, Jennifer A Sherwood, Meghan R McElreath, Ying Qin, Mario Otto

J Mater Chem B· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of iron oxide nanoparticles with the immune system: challenges and opportunities for their use in nano-oncology.
Dana C Baiu, Christopher S Brazel, Yuping Bao, Mario Otto

Curr Pharm Des· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.
Fariba Navid, Paul M Sondel, Raymond Barfield, Barry L Shulkin, Robert A Kaufman, Mario Otto

J Clin Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histiocyte-rich xanthomatous pseudotumor mimicking relapse on positron emission tomography imaging in an adolescent with primary mediastinal diffuse large B-cell lymphoma.
Mario Otto, Barry L Shulkin, Mondira Kundu, John T Sandlund, Scott E Snyder

J Pediatr Hematol Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leading neuroblastoma cells to die by multiple premeditated attacks from a multifunctionalized nanoconstruct.
Peifu Jiao, Hongyu Zhou, Mario Otto, Qingxin Mu, Liwen Li

J Am Chem Soc· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia.
Linda S Sorkin, Mario Otto, William M Baldwin, Emily Vail, Stephen D Gillies

Pain· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the FACS.
Raymond Barfield, Xiaohua Chen, Mario Otto, Rupert Handgretinger

Stem Cells· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
Mario Otto, Xiaohua Chen, William J Martin, Wing Leung, James Knowles

Stem Cells· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis